Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent-Reference-Cited by-同舟云学术

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent

Published:2017-12-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zhu Jianwei¹,Li Rui²,Tiselius Eva³,Roudi Raheleh⁴,Teghararian Olivia³,Suo Chen⁵,Song Huan⁶⁷

Affiliation:

1. Shandong Provincial Hospital Affiliated to Shandong University; Department of Orthopaedics; No.324, Jingwu Road Jinan Shandong China 250021

2. Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University; Thoracic Oncology; Chengdu Sichuan China

3. Karolinska Institutet; Stockholm Sweden

4. Iran University of Medical Sciences; Oncopathology Research Center; Hemmat Street, Next to Milad Tower Teheran Iran 14496-14530

5. Fudan University; Collaborative Innovative Center for Genetic and Development, School of Life Sciences; Songhu road 2005 Shanghai China 200438

6. University of Iceland; Center of Public Health Sciences, Faculty of Medicine; Reykjavík Iceland

7. Karolinska Institutet; Department of Medical Epidemiology and Biostatistics; Stockholm Sweden

Publisher

Wiley

Subject

Pharmacology (medical)

Reference70 articles.

1. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer(START): a randomised, double-blind, phase 3 trial;Butts;Lancet Oncolology,2014

2. Postoperative immunostimulation after complete resection improves survival of patients with stage I non-small cell lung carcinoma;Fujisawa;Cancer,1996

3. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma;Giovanni;Cancer,1996

4. Long-term evaluation of intrapleural Bacillus Calmette-Guérin with or without adjuvant chemotherapy in completely resected stages II and III non-small-cell lung cancer;Macchiarini;American Journal of Clinical Oncology,1991

5. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung:results of a prospective randomized trial;Matthay;Cancer Research,1986

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis;International Journal of Molecular Sciences;2023-05-15

2. Intratumoral Heterogeneity in Lung Cancer;Cancers;2023-05-11

3. Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application;Frontiers in Oncology;2023-02-21

4. Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells;Translational Oncology;2023-01

5. Resistance of Lenvatinib in Hepatocellular Carcinoma;Current Cancer Drug Targets;2022-12